Title
Category
Credits
Event date
Cost
Determinants of Hepatitis C Virus Prevalence in People With Serious Mental Illness: A Systematic Review and Meta-Analysis
  • Hepatitis
  • Medical Conditions
  • Neuropsychiatric Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Increased screening for hepatitis C virus among people with serious mental illness is key to achieving global eradication of the virus.
Translating Clinical Trial Data into Real-World Practice: Examining CKD Screening and Three Patient Case Profiles
  • Renal Disease
  • Adherence
  • Cardiology
  • Comorbidity
  • Diagnostic Tools
  • Education
  • Medical Conditions
  • Primary Care
  • Side Effects
  • Weight
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.
An Individualized Approach to PAH Therapy Based on Clinical Data, Goal-Directed Therapy, and Risk Stratification 
  • Cardiology
  • Comorbidity
  • Education
  • Integrated Care
  • Medical Conditions
  • Pulmonary Disease
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Pulmonary arterial hypertension requires risk stratification to develop goal-directed treatment plans, including combination therapy targeting multiple pathways.